Response dynamics of pediatric patients with chronic myeloid leukemia on imatinib therapy

Research output: Contribution to journalResearch articleContributedpeer-review

Contributors

  • Rick Proschmann - , Technische Universität Dresden (Author)
  • Christoph Baldow - , Institute for Medical Informatics and Biometry, University Hospital Carl Gustav Carus Dresden (Author)
  • Tino Rothe - , Technische Universität Dresden (Author)
  • Meinolf Suttorp - , University Hospital Carl Gustav Carus Dresden (Author)
  • Christian Thiede - , Department of internal Medicine I, Lahey Clinic Medical Center, Burlington, University Hospital Carl Gustav Carus Dresden (Author)
  • Josephine T Tauer - , University Hospital Carl Gustav Carus Dresden (Author)
  • Martin C Müller - , Medical Faculty Mannheim, Heidelberg University  (Author)
  • Andreas Hochhaus - , Abteilung Hämatologie/Onkologie (Author)
  • Ingo Roeder - , Institute for Medical Informatics and Biometry, University Hospital Carl Gustav Carus Dresden, National Center for Tumor Diseases (NCT) Heidelberg (Author)
  • Ingmar Glauche - , Institute for Medical Informatics and Biometry, University Hospital Carl Gustav Carus Dresden (Author)

Details

Original languageEnglish
Pages (from-to)e39-e42
JournalHaematologica
Volume102
Issue number2
Publication statusPublished - Feb 2017
Peer-reviewedYes

External IDs

Scopus 85011601383
PubMed 27856510
PubMedCentral PMC5286951

Keywords

Keywords

  • Adolescent, Antineoplastic Agents/therapeutic use, Child, Child, Preschool, Drug Administration Schedule, Female, Fusion Proteins, bcr-abl/antagonists & inhibitors, Gene Expression, Germany, Humans, Imatinib Mesylate/therapeutic use, Infant, Leukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapy, Male, Protein Kinase Inhibitors/therapeutic use, RNA, Messenger/antagonists & inhibitors, Treatment Outcome